SCHEMBL30116307

SCHEMBL30116307

NC(=O)c1cccc(-c2ncc(N3CCC(CN4CCOCC4)CC3)cn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ STK4 Q13043 1/20 0.46
▸ STK3 Q13188 1/20 0.46
▸ LRRK2 Q5S007 1/20 0.46
▸ OPRK1 P41145 3/20 0.46
▸ PLOD2 O00469 2/20 0.43
▸ PLOD3 O60568 2/20 0.43
▸ PLOD1 Q02809 2/20 0.43
▸ MTOR P42345 2/20 0.42
▸ OPRM1 P35372 2/20 0.42
▸ KMO O15229 1/20 0.41
▸ MELK Q14680 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ HPGDS O60760 1/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ HRH1 P35367 1/20 0.40
▸ CCR3 P51677 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30735978 0.73 ACACB (0.48) CHEK1
SCHEMBL3722032 0.72 KMO (0.58) STK4STK3LRRK2PLOD2PLOD3
SCHEMBL18984633 0.71 APP (0.53) STK4STK3LRRK2OPRK1MTOR
SCHEMBL29933005 0.70 KDM1A (0.62) STK4STK3LRRK2PLOD2PLOD3
SCHEMBL23089563 0.70 PRKDC (0.44) CYP3A4CYP2D6CYP2C9CYP2C19MTOR
SCHEMBL303084 0.70 KMO (0.77) CYP2C9CYP2C19STK4STK3LRRK2
SCHEMBL21627430 0.69 AOC3 (0.61) PLOD2PLOD3PLOD1OPRM1KMO
Hydrochloric Acid SCHEMBL14742166 0.69 KMO (0.74) CYP2C9CYP2C19STK4STK3LRRK2
SCHEMBL3719688 0.69 HRH3 (0.59) HDAC1
SCHEMBL29367 0.68 MAPT (0.46) CYP3A4CYP2D6CYP2C9CYP2C19HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022245061-A1 BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT 에이치케이이노엔 주식회사 2022-11-24 — — WO disclosed
Send feedback